Claims for Patent: 8,226,929
✉ Email this page to a colleague
Summary for Patent: 8,226,929
| Title: | Contrast agents for myocardial perfusion imaging |
| Abstract: | The present disclosure is directed, in part, to compounds and methods for imaging myocardial perfusion, comprising administering to a patient a contrast agent which comprises a compound that binds MC-1, and an imaging moiety, and scanning the patient using diagnostic imaging. |
| Inventor(s): | David S. Casebier, Simon P. Robinson, Ajay Purohit, Heike S. Radeke, Michael T. Azure, Douglas D. Dischino |
| Assignee: | Bristol Myers Squibb Pharma Co, Lantheus Medical Imaging Inc, ACP Lantern Acquisition Inc |
| Application Number: | US12/014,161 |
| Patent Claims: |
1. A method for detecting, imaging or monitoring myocardial perfusion, comprising: administering to a patient a sterile formulation comprising a compound of the following formula: scanning the patient using diagnostic imaging. 2. A method for detecting, imaging, or monitoring myocardial perfusion, comprising: administering to a patient a contrast agent; and scanning the patient using diagnostic imaging, wherein the contrast agent is 3. A method for detecting, imaging, or monitoring myocardial perfusion, comprising: administering to a patient a contrast agent; and scanning the patient using diagnostic imaging, wherein the contrast agent is 4. A method for detecting, imaging, or monitoring myocardial perfusion, comprising: administering to a patient a contrast agent; and scanning the patient using diagnostic imaging, wherein the contrast agent is |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch